 |
| Shailesh Ayyangar |
Sanofi's ($SNY) known for its emerging-markets prowess, but we all need a little help sometimes. To aid it with marketing its oncology lineup in India, the French drugmaker has brought on local company Emcure Pharmaceuticals, PMLiVE reports. Emcure will be responsible for drugs Taxotere, Jevtana, Fludara and Fasturtec, and doctors and patients "will now have access--under one roof--to one of the most comprehensive and complementing oncology portfolios in India," Shailesh Ayyangar, head of Sanofi's Indian subsidiary, told the publication. Report | More